secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2025-03-12T23:59:59+00:00
Accession:  0001213900-25-022858
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital extends business combination deadline to April 11 via $15K trust deposit
--------------------------------------------------------------------------------

- Deposited $15,063.74 into trust to extend deadline from March 11 to April 11, 2025.
- Funding via convertible promissory note from Scilex (SCLX) with principal up to $180,000.
- Note bears no interest, convertible into Class A shares at $10.00 per share upon closing.
- Remaining $59,545.08 under note available for future one-month extensions.
- Company is a blank check SPAC seeking a merger or acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025022858/0001213900-25-022858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025022858/ea0234000-8k425_denalicap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-022858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer